ContextVision files new patent for digital pathology

Digital Pathology, Investor News 2016-06-29
This important step in ContextVision’s deep learning strategy generates the opportunity for a leading role within digital pathology, a market estimated to be worth $157 million USD by 2018. STOCKHOLM – June 29, 2016 – ContextVision, the leading provider of medical image processing software, has filed a patent for a new method using high-precision deep learning […]
Read More

ContextVision awarded research grant to develop new technology

Digital Pathology, Home, Investor News 2015-07-09
ContextVision AB (OSE: COV), the medical imaging software company, has together with its academic partner been awarded a research grant of € 683,000 for a research program aimed at developing new imaging technology within prostate cancer and digital pathology. The technology under development is expected to expand ContextVision’s market footprint significantly. The research program is […]
Read More